MedTrace Logo

The Effect of Velocity Training in Functionally Limited Elderly

NCT01211496 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2016-10-04

No results posted yet for this study

Summary

We are exploring a unique weight-training program for men and women 65 years or older that emphasizes high speed training. We believe that the speed at which muscles move may be more important to the performance of functional tasks than how strong the muscles are. We are comparing velocity training with traditional strength training to determine which method has the greatest effects on muscle strength, speed of movement, functional performance and physical disability. We believe that higher speed training will improve these measures to a greater extent than simply training for increased muscle strength.

Aging also results in loss of bone mass, which increases the risk for falls and fractures. Strength training also has been shown to maintain bone mass in the elderly, but no studies have examined high velocity resistance training and maintenance of bone mass. We believe it is important to examine this aspect of velocity training before recommendations can be made.

Conditions

  • Aging

Interventions

BEHAVIORAL

High-speed power training

High speed resistance training, 3 sessions per week for 12 weeks

BEHAVIORAL

Slow-speed strength training

Slow speed resistance training, 3 sessions per week for 12 weeks

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • University of Missouri-Columbia

    lead OTHER

Principal Investigators

  • Stephen P Sayers, Ph.D. · University of Missouri-Columbia School of Health Professions Physical Therapy Dept

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2008-05-31
Completion
2008-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01211496 on ClinicalTrials.gov